{
  "ptid_time": "116_S_4195_2011-08-31",
  "img_path": "/data/qiuhui/data/adni/images/116_S_4195/2011-08-31/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 18,408 mm³, 38.7% below the reference mean. With a Z-score of -0.92 (17.9th percentile), this represents normal volume ; hippocampal volume measures 5,948 mm³, 25.9% below the reference mean. With a Z-score of -2.59 (0.5th percentile), this represents significant atrophy; whole brain volume measures 966,403 mm³, 14.8% below the reference mean. With a Z-score of -2.10 (1.8th percentile), this represents significant atrophy; entorhinal cortex volume measures 2,961 mm³, 30.5% below the reference mean. With a Z-score of -2.11 (1.7th percentile), this represents significant atrophy; fusiform gyrus volume measures 16,380 mm³, 17.7% below the reference mean. With a Z-score of -1.47 (7.0th percentile), this represents mild atrophy; middle temporal gyrus volume measures 16,800 mm³, 25.0% below the reference mean. With a Z-score of -2.06 (2.0th percentile), this represents significant atrophy. ",
  "text_data": "Age is 62.2 years. Gender is Male. Education: 16 years. Handedness: Right. Race: White. Medical history: Head, Eyes, Ears, Nose and Throat; Musculoskeletal; Endocrine-Metabolic; Smoking. MMSE: 21.0. MoCA: 11.0. Logical Memory: 0.0. Laboratory findings: MCHC: 36.00 (significant elevated); Triglycerides (GPO): 272.00 (significant elevated). APOEε4 alleles: 2.0. Biomarker levels: Florbetapir (AV45): 1.41 SUVR (significant elevated); Amyloid beta: 433.90 pg/mL (moderate reduced); Total tau: 533.30 pg/mL (profound elevated); Phosphorylated tau: 55.81 pg/mL (profound elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient exhibits significant atrophy in key Alzheimer's-related regions (hippocampus, whole brain, entorhinal cortex, middle temporal gyrus) alongside profound biomarker abnormalities (elevated tau, reduced Aβ, and positive AV45 PET). Cognitive scores (MMSE 21, MoCA 11) indicate substantial impairment. The APOE4 homozygosity further increases Alzheimer's risk.  \n\n**Diagnosis:** Dementia (likely Alzheimer’s disease)  \n**Confidence:** High",
  "timestamp": "2025-07-26T12:08:59.102608"
}